Articles related to ‘Neurology’
-
Atomoxetine (Strattera) for ADHD: risk of psychotic or manic symptoms
-
Metoclopramide and tardive dyskinesia: FDA adds boxed warning
-
Barbiturates review: a video lecture
-
Anticonvulsants MCQS for USMLE
-
EMEA reviewed methylphenidate (Ritalin) for ADHD and issued recommendations for its safer use
-
Atomoxetine (Strattera) and the risk of serious hepatic damage. FDA recommendations
-
Important update on safety information of botulinum toxin type A (Botox)
-
Natalizumab (Tysabri) for multiple sclerosis: AAN guideline and recommendations
-
Phenytoin side effects: gingival hypertrophy image
-
Serotonin syndrome
-
Mnemonic to remember which benzodiazepines don’t have hepatic metabolism
-
Phenytoin adverse effects mnemonic
-
Mnemonic for drugs used in the treatment of Parkinson’s disease
-
Pramipexole (Sifrol): dopamine agonist for the treatment of Parkinson’s disease
